Cover Image
市場調查報告書

日本的女性用尿失禁背帶市場分析

Japan Market Report for Female Urinary Incontinence Slings 2017 - MedCore

出版商 iData Research Inc. 商品編碼 499505
出版日期 內容資訊 英文 218 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
日本的女性用尿失禁背帶市場分析 Japan Market Report for Female Urinary Incontinence Slings 2017 - MedCore
出版日期: 2017年05月01日 內容資訊: 英文 218 Pages
簡介

本報告提供日本的女性用尿失禁背帶的市場相關分析,整體市場規模趨勢預測 (銷售量、收益額、平均價格,市場成長率等) ,及主要推動及阻礙市場要素,近幾年的資本交易、市場競爭趨勢,主要企業簡介、市場佔有率等調查,市場整體趨勢 (相關疾病概要,患者數、治療數量,臨床實驗趨勢等) 相關資訊彙整,為您概述為以下內容。

摘要整理

  • 日本的婦產科系醫療設備市場:概要
  • 競爭分析
  • 市場趨勢
  • 市場發展
  • 分析對象市場
  • 主要分析的更新情形
  • 過去的版本

分析方法

  • 分析範圍
  • IDATA的9等級分析方法

疾病概要

  • 人體的基本結構
  • 疾病的症狀和病理
    • 簡介
    • 一般的診斷方法
    • ART的相關指標
      • ART的費用:各國的醫療保險的覆蓋率
    • 異常子宮出血
    • 生殖系相關的婦產科癌症、腫瘤
    • 女性的不孕化的指標
    • 尿失禁
    • 骨盆器官脫垂修復的相關症狀
    • CO2飛梭雷射的相關症狀

產品的評估

  • 產品系列
    • 尿失禁背帶
      • 概要
      • 產品矩陣
  • 在法規方面的課題和回收
  • 臨床實驗趨勢

女性用尿失禁背帶市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 推動及阻礙市場要素
    • 推動市場要素
    • 阻礙市場要素
  • 各企業市場佔有率分析

簡稱一覽

附錄:來自企業的新聞稿

圖表一覽

目錄
Product Code: iDATA_JPGYN17_MC_FUI

Female urinary incontinence affects approximately 10% of the population at some point in their lives. Urinary incontinence affects both women and men; however, there is a greater prevalence of incontinence amongst women. The difference is often attributed to changes that occur during pregnancy and childbirth as well as additional factors such as menopause. There are four main categories recognized for urinary incontinence, with 50% of cases diagnosed as stress urinary incontinence (SUI). Surgical treatment using a urinary incontinence sling is one of the most recommended options to help SUI patients become incontinence-free.

General Report Contents:

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

The female urinary incontinence sling market in Japan differs from the global market because biological slings are not commercially available. Synthetic slings comprise almost an exclusive monopoly for the type of products offered, with autologous tissue repair accounting for a nominal percentage of total procedures. Additionally, synthetic mesh is not sold as individual kits in Japan. Hospitals purchase rolls of synthetic mesh and the physician cuts the mesh to size. The Japanese market is further differentiated by the lack of competition. Boston Scientific and Ethicon are the only two competitors offering products on the market.

In 2016, the female urinary incontinence sling market began to recover slightly. The volatility in the market is attributed towards ongoing scrutiny by healthcare regulatory agencies such as the FDA in the United States and adverse reactions documented by the Japan Society of Obstetrics and Gynecology (JSOG). The controversy surrounding urinary incontinence slings predominantly concerns synthetic slings. Due to the negative side effects publicized about slings, however, procedures using both synthetic and biological slings have decreased globally. The adverse side-effects have resulted in patients and, to a lesser degree, physicians, becoming more cautious about sling procedures. While the repercussions of this controversy will still extend throughout the forecast period, as a result surgeons are giving greater attention to stronger patient consent protocols including full disclaimers of the risks involved.

The negative publicity regarding slings has had the greatest impact in countries without public healthcare. In Japan, there has been a faster response to treat patients with adverse effects with no additional costs for the patient. This has led to fewer lawsuits and complaints regarding the procedure helping to keep the market stable.

Despite the contraction of the urinary incontinence sling market, the number of procedures is still substantial. The number of patients suffering from female urinary incontinence is increasing. The number of patients is also expected to continue increasing over the forecast period, as urinary incontinence affects older demographics.

It is worth noting that biological mesh is not available for female urinary incontinence slings due to the regulatory framework for medical devices in Japan. However, even globally this segment comprises a very small portion of the overall market because many believe that collagen based mesh is not as applicable in this indication compared to other areas such as breast reconstruction or hernia repair. There is also a lack of clinical data supporting the use of biologic mesh over synthetic mesh for the treatment of stress incontinence.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1 JAPAN MARKET FOR GYNECOLOGICAL DEVICES OVERVIEW
  • 1.2 COMPETITIVE ANALYSIS
  • 1.3 MARKET TRENDS
  • 1.4 MARKET DEVELOPMENTS
  • 1.5 MARKETS INCLUDED
  • 1.6 KEY REPORT UPDATES
  • 1.7 VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1 RESEARCH SCOPE
  • 1.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1 BASIC ANATOMY
  • 2.2 DISEASE PATHOLOGY AND DISORDERS
    • 2.2.1 Introduction
    • 2.2.2 General Diagnostics
    • 2.2.3 Indications for Assisted Reproduction Technologies (ART)
      • 2.2.3.1 ART cost: coverage policy and medical insurance in different countries
    • 2.2.4 Abnormal Uterine Bleeding
    • 2.2.5 Gynecologic Cancer and Tumors in Reproductive System
    • 2.2.6 Indications for Female Sterilization
    • 2.2.7 Urinary Incontinence
    • 2.2.8 Indications for Pelvic Organ Prolapse Repair
    • 2.2.9 Indications for CO2 Fractional Laser

PRODUCT ASSESSMENT

  • 3.1 PRODUCT PORTFOLIOS
    • 3.1.1 Urinary Incontinence Sling
      • 3.1.1.1 Introduction
      • 3.1.1.2 Product Matrix for Urinary Incontinence Sling
  • 3.2 REGULATORY ISSUES AND RECALLS
    • 3.2.1 Urinary Incontinence Sling
  • 3.3 CLINICAL TRIALS
    • 3.3.1 Urinary Incontinence Sling

FEMALE URINARY INCONTINENCE SLING MARKET

  • 4.1 INTRODUCTION
  • 4.2 MARKET ANALYSIS AND FORECAST
  • 4.3 DRIVERS AND LIMITERS
    • 4.3.1 Market Drivers
    • 4.3.2 Market Limiters
  • 4.4 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

LIST OF CHARTS

  • Chart 1 1: Gynecological Device Market by Segment, Japan, 2013 - 2023
  • Chart 1 2: Gynecological Device Market by Segment, Japan, 2016 & 2023
  • Chart 4 1: Synthetic Female Urinary Incontinence Sling Market, Japan, 2013 - 2023
  • Chart 4 2: Leading Competitors, Female Urinary Incontinence Sling Market, Japan, 2016

LIST OF FIGURES

  • Figure 1 1: Gynecological Device Market by Segment, Japan, 2016 (1 of 2)
  • Figure 1 2: Gynecological Device Market by Segment, Japan, 2016 (2 of 2)
  • Figure 1 3: Companies Researched in this Report, Japan, 2016
  • Figure 1 4: Factors Impacting the Gynecological Device Market by Segment, Japan (1 of 2)
  • Figure 1 5: Factors Impacting the Gynecological Device Market by Segment, Japan (2 of 2)
  • Figure 1 6: Recent Events in the Gynecological Device Market, Japan, 2012 - 2016
  • Figure 1 7: Gynecological Device Markets Covered, Japan, 2016
  • Figure 1 8: Key Report Updates
  • Figure 1 9: Version History
  • Figure 2 1: Gynecological Disease Overview
  • Figure 2 2: ART Procedure Availability Overview
  • Figure 2 3: ART Procedure Availability Overview
  • Figure 3 1: Class 2 Device Recall: MiniArc Pro Single incision Sling System
  • Figure 3 2: Class 2 Device Recall: AdVance"Male Sling System, American Medical Systems, Inc.
  • Figure 3 3: Class 2 Device Recall: AMS Monarc Subfascial Hammock with Tensioning Suture, American Medical Systems, Inc.
  • Figure 3 4: Class 2 Device Recall: AMS 800 Urinary Control System, American Medical Systems, Inc.
  • Figure 3 5: Class 2 Device Recall: GMD UNIVERSAL URINARY INCONTINENCE SLING, Generic Medical Devices
  • Figure 3 6: MAUDE Adverse Event Reports: C.R. BARD, Inc.
  • Figure 3 7: Urinary Incontinence Sling: Advanced Genital Prolapse Surgery With and Without Mid Urethral Sling to Prevent Stress Urinary Incontinence
  • Figure 3 8: Urinary Incontinence Sling: Collection of Long Term Patient Outcomes Following Implantation of AMS Surgical Devices
  • Figure 3 9: Urinary Incontinence Sling: Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence
  • Figure 3 10: Urinary Incontinence Sling: Trans-obturator Mid-urethral Sling and the Single-incision Sling
  • Figure 3 11: Urinary Incontinence Sling: TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence
  • Figure 3 12: Urinary Incontinence Sling: Safety and Efficacy of PVDF (DynaMesh®-SIS Soft) Retropubic Midurethral Slings
  • Figure 3 13: Urinary Incontinence Sling: The European Study of Altis Single Incision Sling System
  • Figure 3 14: Urinary Incontinence Sling: Post Market Study Of Single Incision Sling Versus Transobturator Sling
  • Figure 3 15: Urinary Incontinence Sling: Combined Treatment for Mixed Incontinence (ESTEEM)
  • Figure 3 16: Urinary Incontinence Sling: TVTO™ X TVTS ™ for Treatment of Stress Urinary Incontinence (TVTOxTVTS)
  • Figure 3 17: Urinary Incontinence Sling: Safety and Efficacy Study of Regen Sling to Treatment SUI
  • Figure 3 18: Urinary Incontinence Sling: The Altis® Single Incision Sling System for Female Stress Urinary Incontinence Study
  • Figure 3 19: Urinary Incontinence Sling: Transobturator Sling Compared With Single-incision Mini-sling
  • Figure 4 1: Synthetic Female Urinary Incontinence Sling Market, Japan, 2013 - 2023
  • Figure 4 2: Drivers and Limiters, Female Urinary Incontinence Sling Market, Japan, 2016
  • Figure 4 3: Leading Competitors, Female Urinary Incontinence Sling Market, Japan, 2016
  • Figure 6 1: Press Release Summary
Back to Top